Patent · US Expired

Compounds derived from oxindoles and their therapeutic application in cancer treatment

US6930124B2 · kind B2 · utility

2Cited by
16References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 10, 2003
Grant dateAug 16, 2005
Priority date
Expiry dateSep 10, 2023

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P35/00
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The invention relates to compounds of formula (I) in which R5 is chosen from the group consisting of: in which R2 is a C1-C3 alkyl groupin which X may be Cl, Br, or Fin which n is between 1 and 3, in the E or Z form, or a mixture of the two isomeric forms, possessing antimitotic, antiproliferative and antivascular properties through inhibition of the polymerization of tubulin into microtubules

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.